Expert panel reviews neuraminidase inhibitors for the prevention and treatment of influenza

(European Centre for Disease Prevention and Control (ECDC)) An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news